Cue Biopharma Inc - fluxo de caixa (NASDAQ:CUE)

Financials

Cash from operating activities -32.49 M-38.84 M-41.81 M-39.96 M-36.33 M-21.69 M -21.69 M Cash from investing activities 4.46 M9.11 M-24.61 M25 M32 K75 K 75 K Cash from financing activities 58.61 M19.23 M53.66 M11.86 M10.24 M26.29 M 26.29 M Free cash flow -33.09 M-39.75 M-41.98 M-39.96 M-36.4 M-21.86 M -21.86 M

Notícias

Cue Biopharma, Inc. (CUE) Discusses CUE-401 R&D Progress and Mechanism for Autoimmune and Inflammatory Diseases - Slideshow (NASDAQ:CUE) 2026-04-09

Cue Biopharma, Inc. (CUE) Discusses CUE-401 R&D Progress and Mechanism for Autoimmune and Inflammatory Diseases Transcript

Cue Biopharma receberá US$ 7,5 milhões da Boehringer Ingelheim

Cue Biopharma nomeia Lucinda Warren como CEO interina

Lucro da Cue Biopharma superou projeções por $0,10; receita supera estimativas

Cue Biopharma earnings beat by $0.10, revenue topped estimates

Cue Biopharma precifica oferta pública de US$ 10 milhões a US$ 0,28 por ação

Cue Biopharma prices $10 million public offering at $0.28 per share

Ações da Cue Biopharma despencam após anúncio de oferta pública

Cue Biopharma stock tumbles on public offering announcement

Cue Biopharma lança oferta pública de ações ordinárias e warrants

Cue Biopharma launches public offering of common stock and warrants